article · AIDS

Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first-line antiretroviral therapy regimen in Zimbabwe

Vinie Kouamou
Tichaona Mapangisana
Chiratidzo E. Ndhlovu
Tendai Washaya
Justen Manasa

20243 citationsOpen accessStellenbosch University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

We found high virological suppression and an increased weight among people initiating on DTG in a resource-limited setting. Encouragingly, HIVDR to DTG remains rare.

Research topics

HIV/AIDS drug development and treatment
HIV Research and Treatment
HIV-related health complications and treatments

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1097/qad.0000000000003830

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.